XML 32 R21.htm IDEA: XBRL DOCUMENT v3.20.2
Description of Business and Significant Accounting Policies (Tables)
9 Months Ended
Sep. 30, 2020
Accounting Policies [Abstract]  
Schedule of Reconciliation of Cash, Cash Equivalents, and Restricted Cash

The following table provides a reconciliation of cash, cash equivalents, and restricted cash reported on the consolidated balance sheets that sum to amounts reported on the consolidated statement of cash flows (in thousands):

 

 

 

September 30, 2020

 

 

December 31, 2019

 

Cash and cash equivalents

 

$

52,398

 

 

$

29,906

 

Restricted cash

 

 

316

 

 

 

316

 

Total cash, cash equivalents, and restricted cash

 

$

52,714

 

 

$

30,222

 

Schedule of Potentially Dilutive Common Stock Equivalent Securities

The computation of basic and diluted net loss per share for the three and nine months ended September 30, 2020 and 2019 excludes the common stock equivalents of the following potentially dilutive securities because their inclusion would be anti-dilutive while the Company is in a net loss position:

 

 

 

Nine Months Ended September 30,

 

 

 

2020

 

 

2019

 

RSUs and Market RSUs (1)

 

 

8,897,020

 

 

 

1,122,283

 

Employee stock purchase plan

 

 

107,003

 

 

 

147,675

 

Common stock options and PNQs

 

 

12,689,522

 

 

 

15,361,337

 

2024 convertible notes

 

 

1,666,667

 

 

 

1,666,667

 

Mann Group convertible note

 

 

14,000,000

 

 

 

14,000,000

 

Common stock warrants

 

 

31,856

 

 

 

31,856

 

Warrants associated with Midcap Credit Facility

 

 

1,171,614

 

 

 

1,171,614

 

Warrants associated with public offering

 

 

 

 

 

23,333,333

 

Total shares

 

 

38,563,682

 

 

 

56,834,765

 

 

(1)

Market RSUs are included at the maximum share delivery percentage (see Note 10 — Stock-Based Compensation Expense).